GlassScriptPhysician profile
Som Kohanzadeh
NPI 1952575342
$7,534.44
in general payments reported to CMS, 2019-2025
41 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,417 · 2020: $2,204 · 2021: $1,726 · 2022: $1,027 · 2023: $630 · 2024: $324 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,161.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,131.54 | 2019-2023 | Puraply |
| Musculoskeletal Transplant Foundation INC. | $1,319.04 | 2019-2024 | |
| Biotissue Holdings INC. | $816.30 | 2021-2025 | |
| Medline Industries LP | $358.43 | 2019-2021 | |
| Sientra, INC. | $344.30 | 2019-2021 | |
| Kerecis Limited | $339.42 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $330.55 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $261.78 | 2019-2025 | Grafix Pl, Oasis, "Acticoat 4"" X 4""" |
| Amniox Medical, INC. | $193.22 | 2020 | |
| Medela LLC | $173.42 | 2019-2020 | |
| Abbvie INC. | $124.09 | 2023-2025 | |
| Allergan, INC. | $116.26 | 2019-2021 | |
| Davol INC. | $107.09 | 2019-2023 | Phasix Mesh |
| Kci USA, INC. | $88.39 | 2020-2023 | Activ.A.C., Promogran Prisma |
| Mimedx Group, INC. | $72.84 | 2024-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $50.27 | 2024 | Novosorb Btm |
| Paratek Pharmaceuticals, INC. | $49.03 | 2022-2023 | Nuzyra |
| Melinta Therapeutics, LLC | $47.33 | 2019-2022 | |
| Tei Medical INC. | $47.24 | 2019 | |
| Misonix INC | $43.20 | 2019-2021 | |
| Mentor Worldwide LLC | $40.72 | 2019 | |
| Tactile Systems Technology INC | $39.40 | 2019 | |
| Polarityte, INC. | $35.59 | 2019 | |
| Tela Bio, INC. | $35.16 | 2020 | |
| Next Science LLC | $33.34 | 2023 | Xperience, Blastx, Surgx |
| Bioventus LLC | $31.72 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $28.57 | 2019 | |
| Sanara Medtech INC. | $27.65 | 2021 | |
| Osiris Therapeutics INC. | $25.11 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $24.34 | 2020 | |
| Hartmann USA, INC. | $23.68 | 2024 | Zetuvit Plus 10x10 P10 |
| Tetraphase Pharmaceuticals, INC. | $21.78 | 2019 | |
| Urgo Medical North America, LLC | $21.75 | 2025 | Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Solta Medical, A Division of Bausch Health US, LLC | $21.55 | 2019 | |
| Aroa Biosurgery Incorporated | $19.92 | 2025 | |
| Celularity INC. | $18.00 | 2019 | |
| Axogen | $16.31 | 2019 | |
| Boston Scientific Corporation | $16.06 | 2020 | |
| Koya Medical, INC. | $13.90 | 2025 | Dayspring, Koya Medical |
| Medivators INC. | $13.49 | 2019 | |
| Avanos Medical | $12.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Som Kohanzadeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.